Useful for initiation of treatment of primary hypogonadism:
- progesterone
- androstenedione
- ethinyl estradiol
- estriol
- estrone
Postmenopausal changes:
- vasomotor
- genital hypertrophy
- improved lipid profiles
- A & B
- A, B & C
Lipid profile/receptor changes associated with oophorectomy:
- decrease in plasma cholesterol
- decrease in LDL receptors
- increase in LDL serum levels
- significant increase in HDL
- significant increase in triglyceride levels
Estrogen therapy: associated with an increase frequency of home
- migraine headaches
- cholestasis
- hypertension
- nausea
- all of the above
Factors influencing osteoporosis development
- calcium intake
- degree of physical activity
- smoking
- A & B
- A, B & C
Nonsteroidal, synthetic agent with estrogenic activity:
- estradiol
- ethinyl estradiol
- diethylstilbestrol
- quinestrol
- estriol
Prolonged, continuous estrogen exposure -- endometrial effects
- hypoplasia
- abnormal leading patterns
- both
- neither
Estrogens: bone effects --
- decrease rate of bone resorption
- stimulates bone formation
- both
- neither
Risk factors for osteoporosis:
- Caucasian
- thin build
- smoking
- family history
- all the above
Antiestrogenic activity
- medroxyprogesterone acetate
- norethindrone
- L-Norgestrel
- A & B
- A, B & C
Progesterone effect(s):
- dramatically increases protein metabolism
- inhibits lipoproteins lipase
- favor fat deposition
- blunts insulin response to glucose
- inhibits ketogenesis
Major uses of progestational hormones:
- hormone replacement
- hormonal contraception
- both
- neither
Progestin(s) without androgenic activity:
- desogestrel
- gestodene
- norgestimate
- all the above
Most important human progestin:
- desogestrel
- dimethisterone
- progesterone
- megestrol acetate
- hydroxyprogesterone
Chronic use of combination hormonal contraceptives on the ovary:
- minimal follicular development
- absence of corpora lutea
- absence of larger follicles
- absence of stromal edema
- all of the above